Paragon Puts Ilast® Center Stage

Ilast(R) is a scientifically-formulated line of lid care and ocular hygiene products designed to support the health of the eye and the tissue that surrounds it.

| From
Ilast ocular care

PORTLAND, Ore., Nov. 8, 2013 (SEND2PRESS NEWSWIRE) -- Leading biopharmaceutical company Paragon BioTeck, Inc. announced today that it plans to launch its new line of products, known as Ilast®, at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast® ocular care products in the U.S. last month, and the company is excited to release these products to ophthalmology professionals.

About Ilast:
Ilast® is a scientifically-formulated line of lid care and ocular hygiene products designed to support the health of the eye and the tissue that surrounds it. Ilast is free from preservatives, thus eliminating many of the allergenic and cytotoxic properties that often cause irritation to the delicate skin around the eye. Ilast products are manufactured using a patented process known as Epifree® Technology.

This process uses low-temperature sterilization to maximize the effectiveness of active ingredients while simultaneously maintaining the microbiological integrity of the product.

About the Annual American Academy of Ophthalmology:
The American Academy of Ophthalmology is the most expansive association of eye care providers, including osteopathic doctors, medical doctors and ophthalmologists in existence. The Academy works to support the professional interests of eye care providers, as well as to promote continuing education and lifelong enrichment.

At the Academy's annual meeting, eye care professionals can attend educational sessions, view exhibits and learn about the newest developments in the field of ophthalmology. This year's meeting is scheduled to take place from November 16 to November 19, 2013.

About Paragon BioTeck, Inc.:
Paragon BioTeck is a privately-held, ophthalmic-focused biopharmaceutical and medical device company pursuing the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight. For more information on the company and its work, visit

News Source:
For more information regarding this press release, please visit:
Like, Share, Save this press release:
  TWEET   SHARE   G+   PIN IT   STUMBLE   LinkedIn   Instapaper   Buffer

Shortlink to this press release:
The content of the above press release was provided by the “news source” (Paragon BioTeck, Inc.) or authorized agency, who is solely responsible for its accuracy. Send2Press® is the originating wire service for this story and content is Copr. © 2013 Paragon BioTeck, Inc. with newswire version Copr. © 2013 Send2Press (a service of Neotrope). All trademarks acknowledged.

Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
STORY READS for this single page only, as of Oct 22 2016:
[ count retired 8.4.16 ]

back to top
REFERENCES: Ilast ocular care, Epifree Technology, Paragon BioTeck Inc, Ilast ocular care, American Academy of Ophthalmology, Epifree Technology, eye care professionals, ocular hygiene products, Horus Pharma, news, press release from Paragon BioTeck, Inc., Nov 8, 2013, Ophthalmology and Vision, Medical, Pharma, Portland, Oregon, Paragon Puts Ilast® Center Stage